Company Filing History:
Years Active: 2001-2018
Title: Innovations of Randall A Scheuerman: A Pioneer in Pharmaceutical Patents
Introduction
Randall A Scheuerman is an accomplished inventor based in Santa Clara, California. With a prolific portfolio of 20 patents, he has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrugs and their applications.
Latest Patents
His recent inventions include crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, which serves as a prodrug of methyl hydrogen fumarate. Scheuerman has disclosed several crystalline forms including Crystalline form 1, Crystalline form 2, Crystalline form 3, and Crystalline form 4, along with methods of synthesis and use, highlighting his commitment to advancing medicinal chemistry.
Career Highlights
Throughout his career, Randall has worked with notable organizations such as Xenoport, Inc. and Syngenta Participations AG. His experience in these companies has undoubtedly shaped his expertise and innovation in the pharmaceutical sector.
Collaborations
Scheuerman has collaborated with esteemed colleagues like Mark A Gallop and Stephen P Raillard, sharing insights and driving advancements in their respective fields.
Conclusion
Randall A Scheuerman stands out as a prominent inventor in the pharmaceutical industry. His contributions, evidenced by his patents and collaborative efforts, continue to influence the development of new therapeutic applications.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.